HEADER VIRAL PROTEIN 07-OCT-21 7SGT TITLE DOMAIN III (EDIII) OF THE POWV E GLYCOPROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE PROTEIN E; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TICK-BORNE POWASSAN VIRUS (STRAIN LB); SOURCE 3 ORGANISM_TAXID: 39008; SOURCE 4 STRAIN: LB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PET KEYWDS POWASSAN VIRUS, NANOPARTICLE IMMUNOGEN, FLAVIVIRUS, MONOCLONAL KEYWDS 2 ANTIBODY, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR R.HARRIS,S.M.CAHILL,D.COWBURN REVDAT 2 22-JUN-22 7SGT 1 JRNL REVDAT 1 18-MAY-22 7SGT 0 JRNL AUTH R.J.MALONIS,G.I.GEORGIEV,D.HASLWANTER,L.A.VANBLARGAN, JRNL AUTH 2 G.FALLON,O.VERGNOLLE,S.M.CAHILL,R.HARRIS,D.COWBURN, JRNL AUTH 3 K.CHANDRAN,M.S.DIAMOND,J.R.LAI JRNL TITL A POWASSAN VIRUS DOMAIN III NANOPARTICLE IMMUNOGEN ELICITS JRNL TITL 2 NEUTRALIZING AND PROTECTIVE ANTIBODIES IN MICE. JRNL REF PLOS PATHOG. V. 18 10573 2022 JRNL REFN ESSN 1553-7374 JRNL PMID 35679349 JRNL DOI 10.1371/JOURNAL.PPAT.1010573 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 3.42 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED XPLOR-NIH 3.2: FINAL REFINEMENT REMARK 3 WITH THE INCLUSION OF SPECIFIC WATER REMARK 4 REMARK 4 7SGT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260224. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 278; 278 REMARK 210 PH : 6.2; 6.2; 6.2 REMARK 210 IONIC STRENGTH : 70; 70; 70 REMARK 210 PRESSURE : 1 ATM; 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : .5 MM [U-15N] DOMAIN III (EDIII) REMARK 210 OF THE POWV E GLYCOPROTEIN, 20 REMARK 210 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 90% H2O/10% D2O; REMARK 210 1 MM [U-15N] DOMAIN III (EDIII) REMARK 210 OF THE POWV E GLYCOPROTEIN, 20 REMARK 210 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 95% H2O/5% D2O; REMARK 210 1 MM [U-15N] DOMAIN III (EDIII) REMARK 210 OF THE POWV E GLYCOPROTEIN, 20 REMARK 210 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D 1H-15N NOESY; REMARK 210 3D 1H-15N TOCSY; HNHA; 2D 1H-13C REMARK 210 HSQC ALIPHATIC; 3D 1H-13C NOESY; REMARK 210 3D 1H-13C NOESY AROMATIC; 13C REMARK 210 HSQC ARO; 3D HNCO; 3D HN(CO)CA; REMARK 210 3D HNCA; 3D HN(COCA)CB; HN(CA)CB; REMARK 210 HN(CO)NH TOCSY; HC(CO)NH TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III HD; AVANCE DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.6.3, NMRPIPE 2.1, REMARK 210 CCPNMR ANALYSIS 2.4, ARIA 2.3, REMARK 210 SIDER REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 HIS A 601 29.88 -150.47 REMARK 500 3 THR A 581 95.76 69.94 REMARK 500 3 ASN A 640 67.65 38.60 REMARK 500 4 SER A 583 -157.94 -110.46 REMARK 500 4 SER A 613 -154.36 -104.09 REMARK 500 4 ASN A 640 73.15 48.89 REMARK 500 4 ASP A 666 -14.32 68.10 REMARK 500 5 TYR A 582 -90.43 -85.53 REMARK 500 5 SER A 583 -164.81 65.26 REMARK 500 5 SER A 613 -168.09 -78.65 REMARK 500 5 ASP A 614 62.01 76.89 REMARK 500 5 ALA A 634 107.06 -45.67 REMARK 500 5 GLU A 644 -168.35 -77.83 REMARK 500 6 THR A 581 -56.67 -151.66 REMARK 500 6 SER A 613 -157.79 -82.31 REMARK 500 6 ASP A 614 60.60 63.92 REMARK 500 6 THR A 677 110.36 69.57 REMARK 500 7 TYR A 582 -125.21 70.88 REMARK 500 7 SER A 583 -161.14 60.32 REMARK 500 7 ASN A 640 74.40 28.16 REMARK 500 7 ASP A 666 -18.77 64.51 REMARK 500 8 THR A 581 -67.47 70.04 REMARK 500 9 HIS A 601 36.26 -164.57 REMARK 500 9 ASN A 640 72.66 -157.70 REMARK 500 10 THR A 581 76.78 -153.06 REMARK 500 10 SER A 583 -162.24 -107.95 REMARK 500 10 ASN A 640 68.93 37.13 REMARK 500 10 GLU A 644 -162.73 -78.56 REMARK 500 10 SER A 676 87.67 65.64 REMARK 500 10 ILE A 678 -65.88 74.09 REMARK 500 11 ASN A 640 71.25 38.23 REMARK 500 12 SER A 583 -156.93 -133.73 REMARK 500 12 SER A 613 -155.07 -140.90 REMARK 500 12 ASP A 614 61.81 64.43 REMARK 500 12 LYS A 615 -155.93 -154.36 REMARK 500 12 ALA A 634 96.85 -68.81 REMARK 500 12 ASN A 640 77.06 41.28 REMARK 500 12 GLU A 644 -166.89 -76.38 REMARK 500 12 THR A 677 99.50 68.49 REMARK 500 13 HIS A 601 26.25 -143.63 REMARK 500 13 ASP A 614 60.85 74.37 REMARK 500 13 ALA A 634 105.68 -47.88 REMARK 500 13 ASN A 640 71.82 33.93 REMARK 500 14 TYR A 582 -97.24 70.57 REMARK 500 14 SER A 583 -132.81 47.53 REMARK 500 14 ASN A 640 74.16 45.12 REMARK 500 15 SER A 613 -164.28 -109.44 REMARK 500 15 ASN A 632 97.47 -68.60 REMARK 500 15 ASN A 640 88.70 -154.02 REMARK 500 15 THR A 677 81.54 42.72 REMARK 500 REMARK 500 THIS ENTRY HAS 73 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7KYL RELATED DB: PDB REMARK 900 SAME PROTEIN BY XRC IN COMPLEX W AB REMARK 900 RELATED ID: 30959 RELATED DB: BMRB REMARK 900 DOMAIN III (EDIII) OF THE POWV E GLYCOPROTEINRICHA DBREF 7SGT A 581 680 UNP Q04538 POLG_POWVL 581 680 SEQADV 7SGT SER A 579 UNP Q04538 EXPRESSION TAG SEQADV 7SGT ASN A 580 UNP Q04538 EXPRESSION TAG SEQADV 7SGT THR A 588 UNP Q04538 ALA 588 CONFLICT SEQADV 7SGT THR A 630 UNP Q04538 ALA 630 CONFLICT SEQADV 7SGT ILE A 631 UNP Q04538 VAL 631 CONFLICT SEQADV 7SGT SER A 646 UNP Q04538 ASN 646 CONFLICT SEQRES 1 A 102 SER ASN THR TYR SER MET CYS ASP LYS THR LYS PHE LYS SEQRES 2 A 102 TRP LYS ARG VAL PRO VAL ASP SER GLY HIS ASP THR VAL SEQRES 3 A 102 VAL MET GLU VAL SER TYR THR GLY SER ASP LYS PRO CYS SEQRES 4 A 102 ARG ILE PRO VAL ARG ALA VAL ALA HIS GLY VAL PRO THR SEQRES 5 A 102 ILE ASN VAL ALA MET LEU ILE THR PRO ASN PRO THR ILE SEQRES 6 A 102 GLU THR SER GLY GLY GLY PHE ILE GLU MET GLN LEU PRO SEQRES 7 A 102 PRO GLY ASP ASN ILE ILE TYR VAL GLY ASP LEU SER GLN SEQRES 8 A 102 GLN TRP PHE GLN LYS GLY SER THR ILE GLY ARG HELIX 1 AA1 ASP A 586 THR A 588 5 3 SHEET 1 AA1 4 PHE A 590 VAL A 597 0 SHEET 2 AA1 4 VAL A 604 TYR A 610 -1 O SER A 609 N LYS A 591 SHEET 3 AA1 4 GLY A 649 GLN A 654 -1 O MET A 653 N VAL A 604 SHEET 4 AA1 4 MET A 635 LEU A 636 -1 N MET A 635 O GLN A 654 SHEET 1 AA2 2 CYS A 617 ARG A 618 0 SHEET 2 AA2 2 THR A 642 ILE A 643 -1 O ILE A 643 N CYS A 617 SHEET 1 AA3 3 VAL A 621 ALA A 625 0 SHEET 2 AA3 3 GLY A 658 VAL A 664 -1 O ILE A 661 N VAL A 624 SHEET 3 AA3 3 LEU A 667 GLN A 673 -1 O TRP A 671 N ASN A 660 SSBOND 1 CYS A 585 CYS A 617 1555 1555 2.03 CISPEP 1 LYS A 615 PRO A 616 1 -3.25 CISPEP 2 LYS A 615 PRO A 616 2 -1.18 CISPEP 3 LYS A 615 PRO A 616 3 1.19 CISPEP 4 LYS A 615 PRO A 616 4 -5.98 CISPEP 5 LYS A 615 PRO A 616 5 -5.05 CISPEP 6 LYS A 615 PRO A 616 6 -2.92 CISPEP 7 LYS A 615 PRO A 616 7 0.61 CISPEP 8 LYS A 615 PRO A 616 8 0.20 CISPEP 9 LYS A 615 PRO A 616 9 -0.17 CISPEP 10 LYS A 615 PRO A 616 10 -3.49 CISPEP 11 LYS A 615 PRO A 616 11 0.59 CISPEP 12 LYS A 615 PRO A 616 12 4.82 CISPEP 13 LYS A 615 PRO A 616 13 -1.70 CISPEP 14 LYS A 615 PRO A 616 14 -0.89 CISPEP 15 LYS A 615 PRO A 616 15 -0.92 CISPEP 16 LYS A 615 PRO A 616 16 1.11 CISPEP 17 LYS A 615 PRO A 616 17 -1.21 CISPEP 18 LYS A 615 PRO A 616 18 0.05 CISPEP 19 LYS A 615 PRO A 616 19 -9.91 CISPEP 20 LYS A 615 PRO A 616 20 -1.84 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1